Peter Unge

Peter Unge appears in our data through filings on Cinclus Pharma Holding AB (publ) shares, published by Finansinspektionen. In total, 9 filings cover trades dated from 18 June 2024 to 20 February 2025.

No open-market sale appears; the market trades are 5 purchases worth €155k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 1 purchase and no sales.

The median purchase comes to €34k. On 4 out of 5 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 20% of cases; the median change was -15.4%. These figures describe past trades and do not predict future prices.

The newest entry dates from 20 February 2025: an open-market purchase of €57k, in Cinclus Pharma Holding AB (publ). Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.